You are hereBiblio / Nanomaterial consumer products and FDA regulation : regulatory challenges and necessary amendments

Nanomaterial consumer products and FDA regulation : regulatory challenges and necessary amendments


By csep - Posted on 16 June 2010

TitleNanomaterial consumer products and FDA regulation : regulatory challenges and necessary amendments
Publication TypeJournal Article
Year of Publication2006
AuthorsKimbrell, George A.
Journalnanotechnology Law and Business
Volume3
Issue3
ISSN Number1546-203X
Abstract

Though a large number of nanotechnology products have are now available for consumers, the U.S. Food and Drug Administration (FDA) has, as of November 2006, has taken no action to account for the fundamentally different properties and possible associated risks of their nanomaterial ingredients. The author first evaluates the FDA's current stance on engineered nanoparticles, and then discusses the recent legal petition filed by his organization, the International Center for Technology Assessment, and others calling the FDA to amend its regulations to address the potential environmental and human health risks association with nanomaterial products.